These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33092235)

  • 81. Prognostic value of CD133
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
    Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients.
    Ilie M; Szafer-Glusman E; Hofman V; Long-Mira E; Suttmann R; Darbonne W; Butori C; Lalvée S; Fayada J; Selva E; Yu W; Marquette CH; Shames DS; Punnoose E; Hofman P
    Oncotarget; 2017 Apr; 8(16):26112-26121. PubMed ID: 28212540
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 84. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mohamed Suhaimi NA; Foong YM; Lee DY; Phyo WM; Cima I; Lee EX; Goh WL; Lim WY; Chia KS; Kong SL; Gong M; Lim B; Hillmer AM; Koh PK; Ying JY; Tan MH
    Mol Oncol; 2015 Apr; 9(4):850-60. PubMed ID: 25605225
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The prognostic role of circulating tumor cells in colorectal cancer.
    Nanduri LK; Hissa B; Weitz J; Schölch S; Bork U
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1077-1088. PubMed ID: 31778322
    [No Abstract]   [Full Text] [Related]  

  • 87. Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study.
    Garrigós N; Gallego J; Guillén-Ponce C; Guaraz P; García-Bautista M; Castillejo A; Gómez-Martínez A; Carrato A; Rodríguez-Lescure A; Soto JL
    Clin Transl Oncol; 2010 Feb; 12(2):142-7. PubMed ID: 20156783
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Genetic and phenotypic profiling of single living circulating tumor cells from patients with microfluidics.
    Dong Z; Wang Y; Xu G; Liu B; Wang Y; Reboud J; Jajesniak P; Yan S; Ma P; Liu F; Zhou Y; Jin Z; Yang K; Huang Z; Zhuo M; Jia B; Fang J; Zhang P; Wu N; Yang M; Cooper JM; Chang L
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315168121. PubMed ID: 38683997
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer.
    Chen L; Zhou W; Ye Z; Zhong X; Zhou J; Chen S; Liu W; Sun Y; Ren L; Tan X; Cui J; Zeng Z; He W; Ke Z
    ACS Appl Mater Interfaces; 2022 Aug; 14(31):35389-35399. PubMed ID: 35904812
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.
    De Angelis ML; Francescangeli F; Nicolazzo C; Signore M; Giuliani A; Colace L; Boe A; Magri V; Baiocchi M; Ciardi A; Scarola F; Spada M; La Torre F; Gazzaniga P; Biffoni M; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):86. PubMed ID: 35260172
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity.
    Miyamoto DT; Ting DT; Toner M; Maheswaran S; Haber DA
    Cold Spring Harb Symp Quant Biol; 2016; 81():269-274. PubMed ID: 28389596
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
    Cayrefourcq L; Thomas F; Mazard T; Assenat E; Assou S; Alix-Panabières C
    Mol Cancer; 2021 Feb; 20(1):30. PubMed ID: 33557844
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility.
    Petrik J; Verbanac D; Fabijanec M; Hulina-Tomašković A; Čeri A; Somborac-Bačura A; Petlevski R; Grdić Rajković M; Rumora L; Krušlin B; Štefanović M; Ljubičić N; Baršić N; Hanžek A; Bočkor L; Ćelap I; Demirović A; Barišić K
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362369
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis.
    He Y; He X; Zhou Y; Luo S
    BMC Cancer; 2023 Jul; 23(1):707. PubMed ID: 37507669
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma.
    Sun YF; Wu L; Liu SP; Jiang MM; Hu B; Zhou KQ; Guo W; Xu Y; Zhong Y; Zhou XR; Zhang ZF; Liu G; Liu S; Shi YH; Ji Y; Du M; Li NN; Li GB; Zhao ZK; Huang XY; Xu LQ; Yu QC; Peng DH; Qiu SJ; Sun HC; Dean M; Wang XD; Chung WY; Dennison AR; Zhou J; Hou Y; Fan J; Yang XR
    Nat Commun; 2021 Jul; 12(1):4091. PubMed ID: 34215748
    [TBL] [Abstract][Full Text] [Related]  

  • 96. New Method for Counting and Picking Out Single Circulating Tumor Cells from Microliter-Volume Samples for Tumor Progression Surveillance and Single-Cell Heterogeneity Analysis.
    Yu H; Yang C; Tai Q; Gao M; Zhang X
    Anal Chem; 2023 Mar; 95(12):5232-5239. PubMed ID: 36913664
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
    Yan S; Guo W; Liu Y; Li K; Wang W
    Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Circulating Tumour Cells as Prognostic Biomarkers in Colorectal Cancer: A Systematic Review.
    Veyrune L; Naumann DN; Christou N
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918012
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
    Alderdice M; Richman SD; Gollins S; Stewart JP; Hurt C; Adams R; McCorry AM; Roddy AC; Vimalachandran D; Isella C; Medico E; Maughan T; McArt DG; Lawler M; Dunne PD
    J Pathol; 2018 May; 245(1):19-28. PubMed ID: 29412457
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Simple Detection and Culture of Circulating Tumor Cells from Colorectal Cancer Patients Using Poly(2-Methoxyethyl Acrylate)-Coated Plates.
    Nomura M; Yokoyama Y; Yoshimura D; Minagawa Y; Yamamoto A; Tanaka Y; Sekiguchi N; Marukawa D; Ichihara M; Itakura H; Matsumoto K; Morimoto Y; Tomihara H; Inoue A; Ogino T; Miyoshi N; Takahashi H; Takahashi H; Uemura M; Kobayashi S; Mizushima T; Anada T; Mori M; Doki Y; Tanaka M; Eguchi H; Yamamoto H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.